Related Experiment Video
Updated: May 10, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
The Older the Patients, the More Aggressive the Prostate Cancer Detected Even Among Those With a Prostate-Specific
Jong Hyun Pyun1, Young Hwii Ko2, Sang Won Kim3
1Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Background:
To investigate the clinicopathologic pattern of prostate cancer (PCa) in elderly patients compared with their younger counterparts with a prostate-specific antigen (PSA) level below the low-risk threshold (< 10 ng/mL), which is often a deciding factor for biopsy.
Methods:
A nationwide database of PCa at the time of biopsy from 2010 to 2020 was constructed from 39 hospitals. Patients were categorized into age groups of < 64 years, 65-69 years, 70-74 years, and ≥ 75 years considering guidelines that recommend PSA testing only for those aged 55-69 years during the study period, the average age of Korean PCa registrants of 70.3 years (2010-2020), and the average life expectancy of Korean males of 80.3 years (2020).
Results:
The mean ± standard deviation age was 70.3 ± 8.2 years, which was normally distributed (kurtosis = 0.095). Among 14,548 subjects, 54.1%, 39.5%, and 6.4% of them had high-risk disease, intermediate-risk disease, and low-risk disease, respectively. Based on three risk parameters, a marked increase in high-risk cancer was observed in the oldest age group (linear combination, P < 0.001). The same pattern was observed among patients with low-risk disease (PSA < 10 ng/mL), who were divided into PSA tiers as follows: 4-5 ng/mL (P < 0.001), 5-6 ng/mL (P < 0.001), 6-7 ng/mL (P < 0.001), 7-8 ng/mL (P < 0.001), 8-9 ng/mL (P = 0.009), and 9-10 ng/mL (P < 0.001). In all PSA tiers between 4 and 10 ng/mL, multivariate analysis demonstrated a significantly higher prevalence of high-risk cancer in the oldest age group than in the youngest age group. In the lowest tier (4-5 ng/mL), 35.2% of those aged over 75 years had high-risk PCa.
Conclusion:
The older the patient, the more aggressive the PCa. Moreover, there was an increase in high-risk PCa in older males compared with younger males even with a PSA level below the low-risk threshold of 10 ng/mL, suggesting the need to strengthen cancer screening policies in the older population.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

